**Core Concept**
Cardiac allografts, like other heart valves, are prone to degenerative changes over time, especially after prolonged periods of immunosuppression. These changes can lead to reduced heart function and clinical symptoms.

**Why the Correct Answer is Right**
The patient's clinical presentation of worsening exercise tolerance, increasing dyspnea, and peripheral edema, combined with a reduced ejection fraction, suggests that the allograft has developed a condition known as _cardiac allograft vasculopathy (CAV)_. CAV is a form of accelerated atherosclerosis that occurs within the graft's coronary arteries, leading to ischemic damage and reduced cardiac function. This condition is a major complication of long-term cardiac transplantation.

**Why Each Wrong Option is Incorrect**
**Option A:** _Rejection_ is an immune response against the allograft, often presenting with symptoms like fever, fatigue, and shortness of breath. While rejection is a concern in cardiac transplantation, the patient's presentation and echocardiography findings do not suggest this diagnosis.

**Option B:** _Dilated cardiomyopathy_ is the underlying condition for which the patient received the cardiac allograft. The patient's current symptoms and echocardiography findings are unlikely to be due to recurrence of the original cardiomyopathy, as the allograft would not have developed these changes simultaneously.

**Option C:** _Hypertrophic cardiomyopathy_ is a genetic disorder characterized by abnormal thickening of the heart muscle. This condition is not directly related to the patient's cardiac transplantation and does not explain the reduced ejection fraction and clinical symptoms.

**Option D:** _Cardiac amyloidosis_ is a condition in which abnormal proteins accumulate in the heart, leading to restrictive cardiomyopathy. While cardiac amyloidosis can cause similar symptoms, the patient's history of cardiac transplantation and echocardiography findings make CAV a more likely diagnosis.

**Clinical Pearl / High-Yield Fact**
Cardiac allograft vasculopathy is a major complication of long-term cardiac transplantation, often presenting with symptoms of heart failure and ischemia. Early detection and management are crucial to prevent graft failure and improve patient outcomes.

**Correct Answer:** C. Cardiac allograft vasculopathy.